OMNI BIO PHARMACEUTICAL, INC. 3

3 · OMNI BIO PHARMACEUTICAL, INC. · Filed Apr 9, 2015

Insider Transaction Report

Form 3
Period: 2014-09-25
Holdings
  • Warrant

    Exercise: $0.25From: 2014-04-18Exp: 2019-12-31Common Stock (1,000,000 underlying)
  • Convertible Note

    Exercise: $0.20From: 2014-06-16Exp: 2015-04-24Common Stock (2,500,000 underlying)
  • Convertible Note

    Exercise: $0.20From: 2014-09-25Exp: 2015-04-24Common Stock (2,500,000 underlying)
  • Convertible Note

    Exercise: $0.20From: 2014-04-25Exp: 2015-04-24Common Stock (2,500,000 underlying)
Footnotes (3)
  • [F1]This Secured Convertible Promissory Note gives the holder the right but not the obligation to convert the principal and accrued interest into common stock at a purchase price per share equal to the lesser of $0.20 or in the event of a follow-on public offering, 65% of the price offered. The note is for up-to $2,0000,000 at 12% interest of which $500,000 was advanced.
  • [F2]Advance of $500,000 under the previously disclosed $2,000,000 Secured Convertible Promissory Note resulting in total drawn principal of $1,000,000.
  • [F3]Advance of $500,000 under the previously disclosed $2,000,000 Secured Convertible Promissory Note resulting in total drawn principal of $1,500,000.

Documents

1 file
  • 3
    form3bohemianomni_3192015.xmlPrimary

    OWNERSHIP DOCUMENT